Johnson & Johnson

NYSE: JNJ
$164.16
-$0.66 (-0.4%)
Closing Price on September 20, 2024

JNJ Articles

News finally broke late Wednesday that there was an official buyout of Pharmacyclics in the works by AbbVie for $21 billion.
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has made its quarterly filing with the Securities & Exchange Commission for its holdings as of December 31, 2014. For all...
thinkstockFebruary 17, 2015: Markets opened lower on Tuesday and finished the morning with a loss. Afternoon trading turned stocks higher on little economic news. Crude oil prices rose today after...
thinkstock February 9, 2015: Markets opened lower on Monday following remarks by Greece’s new president that rattled traders. There was no U.S. economic data out today. Shortly before the closing...
thinkstockFebruary 6, 2015: Markets opened mixed on Friday following the monthly report on unemployment that showed the rate rising to 5.7%, new jobs growing faster than expected, and hourly wage...
Boston Scientific is pushing forward in its long turnaround and is gathering more speed.
Johnson & Johnson reported better than expected fourth-quarter results Tuesday before the market open.
thinkstockJanuary 15, 2015: Markets opened higher on Thursday following an announcement from the Swiss National Bank that it would no longer support the franc at €1.20. Oil prices shot up and...
Thursday's top analyst upgrades, downgrades include Apple, Barrick Gold, Corning, Groupon, Peabody Energy and SolarCity.
Cowen has a long list of stocks that are out of favor at many other firms on Wall Street. These five are leaders in their respective sectors and have big dividends.
One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have upside performance above what was expected.
For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some radical...
Geron hasannounced that it entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech to develop and commercialize imetelstat.
thinkstockNovember 4, 2014: Markets opened slightly lower on Tuesday as the bottom fell out on crude oil which went on to finish the day down 2% at just above $77 a barrel. New 52-week highs were...